- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 10.7 Amendment to Research and Development Agreement
- 10.8 License Agreement
- 10.28 Employment Agreement Addendum #1
- 10.30 Separation of Employment Agreement - Terri B. Sebree
- 10.33 Separation of Employment Agreement - Jane H. Hollingsworth
- 23 Consent of KPMG LLP
- 31.1 Section 302 CEO Certification
- 31.2 Section 302 CFO Certification
- 32 Section 906 CEO and CFO Certifications
Exhibit 23
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Auxilium Pharmaceuticals, Inc.:
We consent to the incorporation by reference in the registration statement (No. 333-117595) on Form S-8 of Auxilium Pharmaceuticals, Inc. of our report dated April 15, 2005, with respect to the consolidated balance sheets of Auxilium Pharmaceuticals, Inc. and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of operations, redeemable convertible preferred stock, stockholders’ equity (deficit) and comprehensive loss, and cash flows for each of the years in the three-year period ended December 31, 2004, which report appears in the December 31, 2004, annual report on Form 10-K of Auxilium Pharmaceuticals, Inc..
/s/ KPMG LLP
Philadelphia, Pennsylvania
April 15, 2005